We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$78.8B
AUM Growth
+$7.07B
Cap. Flow
+$2.22B
Cap. Flow %
2.81%
Top 10 Hldgs %
22%
Holding
3,838
New
237
Increased
1,800
Reduced
1,491
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 9.56%
3 Healthcare 8.56%
4 Industrials 6.35%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITS
3526
Lite Strategy Inc
LITS
$29.6M
$47K ﹤0.01%
+946
New +$35.2K
MSI icon
3527
CALL
Motorola Solutions
MSI
$76.5B
$47K ﹤0.01%
80,600
-8,300
-9% -$1.37M
NVAX icon
3528
Novavax
NVAX
$1.3B
$47K ﹤0.01%
+11,862
New +$51.4K
DSE
3529
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$47K ﹤0.01%
1,218
-300
-20% -$11.4K
UUU icon
3530
Universal Safety Products Inc
UUU
$10.9M
$46K ﹤0.01%
73,513
CDTX
3531
DELISTED
Cidara Therapeutics
CDTX
$45K ﹤0.01%
588
-62
-10% -$2.84K
MUX icon
3532
McEwen Inc
MUX
$1.18B
$44K ﹤0.01%
3,494
-500
-13% -$7.07K
PLUR icon
3533
Pluri
PLUR
$19.9M
$43K ﹤0.01%
1,365
-169
-11% -$4.84K
AGRX
3534
DELISTED
Agile Therapeutics
AGRX
$43K ﹤0.01%
+9
New +$31.4K
OKE icon
3535
CALL
Oneok
OKE
$56.9B
$41K ﹤0.01%
25,600
+1,000
+4% +$71.5K
NTBL
3536
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$41K ﹤0.01%
983
-143
-13% -$6.18K
PFE icon
3537
CALL
Pfizer
PFE
$154B
$40K ﹤0.01%
213,224
+5,270
+3% +$188K
LLEX
3538
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$40K ﹤0.01%
105,000
ACTG icon
3539
Acacia Research
ACTG
$465M
$39K ﹤0.01%
14,840
-10,000
-40% -$27.4K
CLMT icon
3540
Calumet Specialty Products
CLMT
$3.96B
$37K ﹤0.01%
10,142
-2,898
-22% -$10K
AHT
3541
Ashford Hospitality Trust
AHT
$20.7M
$36K ﹤0.01%
13
-2
-13% -$5.6K
ALL icon
3542
CALL
Allstate
ALL
$68.2B
$36K ﹤0.01%
20,700
+9,500
+85% +$1.04M
EXK
3543
Endeavour Silver
EXK
$3.03B
$36K ﹤0.01%
14,770
-75,097
-84% -$170K
CDR
3544
DELISTED
Cedar Realty Trust, Inc
CDR
$36K ﹤0.01%
+1,856
New +$36.1K
ADAP
3545
DELISTED
Adaptimmune Therapeutics
ADAP
$35K ﹤0.01%
29,411
+3,546
+14% +$3.78K
PRTY
3546
DELISTED
Party City Holdco Inc.
PRTY
$35K ﹤0.01%
15,062
+3,762
+33% +$14.2K
DHF
3547
BNY Mellon High Yield Strategies Fund
DHF
$173M
$34K ﹤0.01%
11,088
ANIX icon
3548
Anixa Biosciences
ANIX
$111M
$33K ﹤0.01%
10,040
DOW icon
3549
CALL
Dow Inc
DOW
$22.1B
$33K ﹤0.01%
+13,100
New +$677K
GM icon
3550
CALL
General Motors
GM
$77.2B
$33K ﹤0.01%
+30,400
New +$1.1M

Similar funds

Raymond James & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Raymond James & Associates held 3,838 positions worth $78.8B, up 9.9% from $71.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q4 2019 filing shows 237 new, 1,800 increased, 1,491 reduced and 179 closed positions. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2019 buy was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M.
  • Raymond James & Associates added most to Vanguard High Dividend Yield ETF in Q4 2019, an estimated $672M increase.
  • Raymond James & Associates's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $325M.
  • Raymond James & Associates fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $45.9M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $78.8B portfolio in Q4 2019.
  • Raymond James & Associates opened 237 new positions and closed 179 in Q4 2019.
  • Raymond James & Associates's portfolio value rose 9.9% quarter-over-quarter to $78.8B.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.